<p>Cardiol Therapeutics Inc.（TSE:CRDL - 獲取免費報告）的股票在週一交易中下跌了 14.6%。該公司的股價最低曾達到 C$1.24，最後交易價為 C$1.29。在午盤交易中，約有 551,069 股成交，較平均每日成交量 108,983 股增加了 406%。該股票此前收盤價為 C$1.51。</p>
<p>獲取 <strong>Cardiol Therapeutics</strong> 的提醒：</p>
<h2>Cardiol Therapeutics 股票表現</h2>
<p>該公司的 50 日簡單移動平均線為 C$1.50，200 日簡單移動平均線為 C$1.65。公司的流動比率為 2.49，速動比率為 6.84，債務與股本比率為 1.59。公司的市值為 C$1.29 億，市盈率為-3.15，貝塔值為 1.31。</p>
<p>Cardiol Therapeutics（TSE:CRDL - 獲取免費報告）最近於 11 月 13 日（星期四）發佈了其財報。該公司報告本季度每股收益為 C($0.12)。整體來看，研究分析師預計 Cardiol Therapeutics Inc.在當前財政年度將發佈每股收益-0.49。</p>
<h2>關於 Cardiol Therapeutics</h2>
<p>（獲取免費報告）</p>
<p>Cardiol Therapeutics Inc NASDAQ: CRDLTSX: CRDL 是一家臨牀階段的生命科學公司，專注於抗炎和抗纖維化療法的研究與臨牀開發，以治療心臟病。公司的主要藥物候選者 CardiolRxTM（大麻二酚）口服溶液，經過藥品製造，並正在進行臨牀開發，用於治療心臟病。</p>
<h2>瞭解更多</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Cardiol Therapeutics</li>
<li>比較和交易高市盈率股票</li>
<li>國會再次超越市場——這是他們購買的三隻股票</li>
<li>擁有債券的風險</li>
<li>與三隻頂級零售 ETF 一起購物</li>
<li>羅素 2000 指數，投資者如何利用它進行盈利交易</li>
<li>如果 D-Wave 風險太大，考慮這三隻量子 ETF 進行多樣化投資</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資$1,000 在 Cardiol Therapeutics 嗎？</h2>
<p>在考慮 Cardiol Therapeutics 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Cardiol Therapeutics 並不在名單上。</p>
<p>雖然 Cardiol Therapeutics 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

CRDL

<p>Cardiol Therapeutics (TSE:CRDL) 的股價下跌了 14.6%，至 1.29 加元，交易量較平均水平上升了 406%。該股票的 50 日移動平均價為 1.50 加元，200 日平均價為 1.65 加元。公司報告的季度每股收益為 C($0.12)，專注於開發心臟病治療方案。分析師目前對該股票的評級為持有，建議其他股票可能是更好的投資選擇</p>

<p>Shares of Cardiol Therapeutics Inc. (TSE:CRDL - Get Free Report) were down 14.6% during trading on Monday . The company traded as low as C$1.24 and last traded at C$1.29. Approximately 551,069 shares traded hands during mid-day trading, an increase of 406% from the average daily volume of 108,983 shares. The stock had previously closed at C$1.51.</p>
<div class="lb-trans"><p>Cardiol Therapeutics Inc.（TSE:CRDL - 獲取免費報告）的股票在週一交易中下跌了 14.6%。該公司的股價最低曾達到 C$1.24，最後交易價為 C$1.29。在午盤交易中，約有 551,069 股成交，較平均每日成交量 108,983 股增加了 406%。該股票此前收盤價為 C$1.51。</p>
</div><p>Get <strong>Cardiol Therapeutics</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Cardiol Therapeutics</strong> 的提醒：</p>
</div><h2>Cardiol Therapeutics Stock Performance</h2>
<div class="lb-trans"><h2>Cardiol Therapeutics 股票表現</h2>
</div><p>The firm's 50-day simple moving average is C$1.50 and its two-hundred day simple moving average is C$1.65. The company has a current ratio of 2.49, a quick ratio of 6.84 and a debt-to-equity ratio of 1.59. The company has a market cap of C$129.00 million, a PE ratio of -3.15 and a beta of 1.31.</p>
<div class="lb-trans"><p>該公司的 50 日簡單移動平均線為 C$1.50，200 日簡單移動平均線為 C$1.65。公司的流動比率為 2.49，速動比率為 6.84，債務與股本比率為 1.59。公司的市值為 C$1.29 億，市盈率為-3.15，貝塔值為 1.31。</p>
</div><p>Cardiol Therapeutics (TSE:CRDL - Get Free Report) last released its earnings results on Thursday, November 13th. The company reported C($0.12) earnings per share (EPS) for the quarter. As a group, research analysts anticipate that Cardiol Therapeutics Inc. will post -0.49 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Cardiol Therapeutics（TSE:CRDL - 獲取免費報告）最近於 11 月 13 日（星期四）發佈了其財報。該公司報告本季度每股收益為 C($0.12)。整體來看，研究分析師預計 Cardiol Therapeutics Inc.在當前財政年度將發佈每股收益-0.49。</p>
</div><h2>About Cardiol Therapeutics</h2>
<div class="lb-trans"><h2>關於 Cardiol Therapeutics</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Cardiol Therapeutics Inc NASDAQ: CRDLTSX: CRDL is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease.</p>
<div class="lb-trans"><p>Cardiol Therapeutics Inc NASDAQ: CRDLTSX: CRDL 是一家臨牀階段的生命科學公司，專注於抗炎和抗纖維化療法的研究與臨牀開發，以治療心臟病。公司的主要藥物候選者 CardiolRxTM（大麻二酚）口服溶液，經過藥品製造，並正在進行臨牀開發，用於治療心臟病。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Cardiol Therapeutics</li>
<li>Comparing and Trading High PE Ratio Stocks</li>
<li>Congress Beat the Market Again—Here Are the 3 Stocks They Bought</li>
<li>The Risks of Owning Bonds</li>
<li>Go on a Shopping Spree With 3 Top Retail ETFs</li>
<li>Russell 2000 Index, How Investors Use it For Profitable Trading</li>
<li>If D-Wave Is Too Risky, Consider These 3 Quantum ETFs for Diversification</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Cardiol Therapeutics</li>
<li>比較和交易高市盈率股票</li>
<li>國會再次超越市場——這是他們購買的三隻股票</li>
<li>擁有債券的風險</li>
<li>與三隻頂級零售 ETF 一起購物</li>
<li>羅素 2000 指數，投資者如何利用它進行盈利交易</li>
<li>如果 D-Wave 風險太大，考慮這三隻量子 ETF 進行多樣化投資</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cardiol Therapeutics Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在 Cardiol Therapeutics 嗎？</h2>
</div><p>Before you consider Cardiol Therapeutics, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Cardiol Therapeutics 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardiol Therapeutics wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Cardiol Therapeutics 並不在名單上。</p>
</div><p>While Cardiol Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Cardiol Therapeutics 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Cardiol Therapeutics (TSE:CRDL) 股價下跌 14.6% - 以下是原因